Evaluation of Gabapentin as a Treatment of Breakthrough Cancer Pain Caused by Metastatic Prostate Adenocarcinoma

INTRODUCTION: Breakthrough Cancer Pain (BTcP) is defined as a temporary increase in pain that occurs spontaneously. The use of gabapentin is believed to be able to reduce pain complaints in patients with BTcP. However, research to support the efficacy of gabapentin in relieving pain in patients with...

Descripción completa

Detalles Bibliográficos
Autores principales: Ismy, Jufriady, Emril, Dessy R, Khalilullah, Said Alfin, Mauny, Muhammad Puteh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10558050/
https://www.ncbi.nlm.nih.gov/pubmed/37808465
http://dx.doi.org/10.2147/JPR.S422769

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10558050/
https://www.ncbi.nlm.nih.gov/pubmed/37808465
http://dx.doi.org/10.2147/JPR.S422769

Ejemplares similares